FDA Enforcement Class II Terminated

ReShape Integrated Dual Balloon System, Gen 1, Catalog No. RSM110, Model No. 01-0013-001 The ReShape Integrated Dual Balloon System is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a Body Mass Index (BMI) of 30 40 kg/m2 and one or more obesity related comorbid conditions. It is indicated for use in adult patients who have failed weight reduction with diet and exercise alone.

Recall: Z-2552-2016 · Reported August 24, 2016

Enforcement

Recall Number
Z-2552-2016
Event ID
74781
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Reshape Medical Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
August 24, 2016
Initiation Date
May 4, 2016
Classification Date
August 17, 2016
Termination Date
August 17, 2016
Address
100 Calle Iglesia, N/A, San Clemente, CA, 92672-7502, United States

Description

ReShape Integrated Dual Balloon System, Gen 1, Catalog No. RSM110, Model No. 01-0013-001 The ReShape Integrated Dual Balloon System is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a Body Mass Index (BMI) of 30 40 kg/m2 and one or more obesity related comorbid conditions. It is indicated for use in adult patients who have failed weight reduction with diet and exercise alone.

Reason

Due to a suspected misalignment of the connection between the proximal balloon cap of the implant and the delivery catheter. The possible misalignment is the result of an assembly error during manufacturing and may lead to leakage of saline solution during the balloon inflation procedure.

Code Info

160317-001, 160371-002, 160317-003, 160324-010.

Distribution

US: Distribution to the states of : NY, OH and CA.

Quantity

56 units